SB202190
Contact us: [email protected]
SB202190 (p38 MAP kinase inhibitor) |
SIH-473-5MG |
Stressmarq |
5 mg |
EUR 192 |
|
Description: The substance SB202190 is a p38 map kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is pale yellow solid which is soluble in methanol, DMSO or acetone; slightly soluble in ethyl acetate. |
SB-222200 |
A3795-10 |
ApexBio |
10 mg |
EUR 240 |
Description: SB 222200 is a selective and potent antagonist of NK-3 receptor [1].Neurokinin-3 (NK-3) receptor is a member of the G-protein-coupled superfamily and functions as a receptor for tachykinin. |
SB-222200 |
A3795-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 258 |
Description: SB 222200 is a selective and potent antagonist of NK-3 receptor [1].Neurokinin-3 (NK-3) receptor is a member of the G-protein-coupled superfamily and functions as a receptor for tachykinin. |
SB-222200 |
A3795-50 |
ApexBio |
50 mg |
EUR 841.2 |
Description: SB 222200 is a selective and potent antagonist of NK-3 receptor [1].Neurokinin-3 (NK-3) receptor is a member of the G-protein-coupled superfamily and functions as a receptor for tachykinin. |
SB-674042 |
A3800-10 |
ApexBio |
10 mg |
EUR 350.4 |
Description: SB-674042 is a specific, high-affinity OX1 selective antagonist. |
SB-674042 |
A3800-25 |
ApexBio |
25 mg |
EUR 717.6 |
Description: SB-674042 is a specific, high-affinity OX1 selective antagonist. |
SB-674042 |
A3800-5 |
ApexBio |
5 mg |
EUR 216 |
Description: SB-674042 is a specific, high-affinity OX1 selective antagonist. |
SB525334 |
A5602-100 |
ApexBio |
100 mg |
EUR 727.2 |
Description: SB525334 is a potent inhibitor of transforming growth factor-beta1 (TGF-beta1) receptor, activin receptor-like kinase (ALK5). It specifically inhibits ALK5 with IC50 value of 14.3nM, which shows 4-fold higher potency against ALK4 [1]. |
SB525334 |
A5602-25 |
ApexBio |
25 mg |
EUR 268.8 |
Description: SB525334 is a potent inhibitor of transforming growth factor-beta1 (TGF-beta1) receptor, activin receptor-like kinase (ALK5). It specifically inhibits ALK5 with IC50 value of 14.3nM, which shows 4-fold higher potency against ALK4 [1]. |
SB525334 |
A5602-5 |
ApexBio |
5 mg |
EUR 129.6 |
Description: SB525334 is a potent inhibitor of transforming growth factor-beta1 (TGF-beta1) receptor, activin receptor-like kinase (ALK5). It specifically inhibits ALK5 with IC50 value of 14.3nM, which shows 4-fold higher potency against ALK4 [1]. |
SB525334 |
A5602-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 129.6 |
Description: SB525334 is a potent inhibitor of transforming growth factor-beta1 (TGF-beta1) receptor, activin receptor-like kinase (ALK5). It specifically inhibits ALK5 with IC50 value of 14.3nM, which shows 4-fold higher potency against ALK4 [1]. |
SB525334 |
A5602-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: SB525334 is a potent inhibitor of transforming growth factor-beta1 (TGF-beta1) receptor, activin receptor-like kinase (ALK5). It specifically inhibits ALK5 with IC50 value of 14.3nM, which shows 4-fold higher potency against ALK4 [1]. |
SB705498 |
A8519-10 |
ApexBio |
10 mg |
EUR 268.8 |
Description: PKi: 7.6 for human TRPV1 receptor Vanilloid receptor-1 (TRPV1) is a nonselective cation channel, predominantly expressed by sensory neurons, playing a key role in the detection of noxious painful stimuli such as capsaicin, heat, and acid. |
SB705498 |
A8519-5 |
ApexBio |
5 mg |
EUR 170.4 |
Description: PKi: 7.6 for human TRPV1 receptor Vanilloid receptor-1 (TRPV1) is a nonselective cation channel, predominantly expressed by sensory neurons, playing a key role in the detection of noxious painful stimuli such as capsaicin, heat, and acid. |
SB705498 |
A8519-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 181.2 |
Description: PKi: 7.6 for human TRPV1 receptor Vanilloid receptor-1 (TRPV1) is a nonselective cation channel, predominantly expressed by sensory neurons, playing a key role in the detection of noxious painful stimuli such as capsaicin, heat, and acid. |
SB705498 |
A8519-50 |
ApexBio |
50 mg |
EUR 964.8 |
Description: PKi: 7.6 for human TRPV1 receptor Vanilloid receptor-1 (TRPV1) is a nonselective cation channel, predominantly expressed by sensory neurons, playing a key role in the detection of noxious painful stimuli such as capsaicin, heat, and acid. |
SB-334867 |
B1281-10 |
ApexBio |
10 mg |
EUR 184.8 |
Description: SB-334867 is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
SB-334867 |
B1281-25 |
ApexBio |
25 mg |
EUR 324 |
Description: SB-334867 is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
SB-334867 |
B1281-5 |
ApexBio |
5 mg |
EUR 132 |
Description: SB-334867 is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
SB-334867 |
B1281-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 142.8 |
Description: SB-334867 is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
SB-334867 |
B1281-50 |
ApexBio |
50 mg |
EUR 482.4 |
Description: SB-334867 is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
SB590885 |
B1406-10 |
ApexBio |
10 mg |
EUR 226.8 |
Description: SB590885 is a potent and selective inhibitor of B-Raf kinase with Ki value of 0.16nM [1].SB590885 is a potent inhibitor of oncogenic B-Raf protein kinase with Ki value of 0.16nM. |
SB590885 |
B1406-100 |
ApexBio |
100 mg |
EUR 1144.8 |
Description: SB590885 is a potent and selective inhibitor of B-Raf kinase with Ki value of 0.16nM [1].SB590885 is a potent inhibitor of oncogenic B-Raf protein kinase with Ki value of 0.16nM. |
SB590885 |
B1406-250 |
ApexBio |
250 mg |
EUR 1980 |
Description: SB590885 is a potent and selective inhibitor of B-Raf kinase with Ki value of 0.16nM [1].SB590885 is a potent inhibitor of oncogenic B-Raf protein kinase with Ki value of 0.16nM. |
SB590885 |
B1406-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 268.8 |
Description: SB590885 is a potent and selective inhibitor of B-Raf kinase with Ki value of 0.16nM [1].SB590885 is a potent inhibitor of oncogenic B-Raf protein kinase with Ki value of 0.16nM. |
SB590885 |
B1406-50 |
ApexBio |
50 mg |
EUR 727.2 |
Description: SB590885 is a potent and selective inhibitor of B-Raf kinase with Ki value of 0.16nM [1].SB590885 is a potent inhibitor of oncogenic B-Raf protein kinase with Ki value of 0.16nM. |
SB743921 |
B1590-10 |
ApexBio |
10 mg |
EUR 350.4 |
Description: SB743921 is an inhibitor of kinesin spindle protein (KSP) with Ki value of 0.1nM [1].As an inhibitor of mitotic kinesin KSP, SB743921 causes cell cycle arrest in mitosis, results in cell death. |
SB743921 |
B1590-200 |
ApexBio |
200 mg |
EUR 2346 |
Description: SB743921 is an inhibitor of kinesin spindle protein (KSP) with Ki value of 0.1nM [1].As an inhibitor of mitotic kinesin KSP, SB743921 causes cell cycle arrest in mitosis, results in cell death. |
SB743921 |
B1590-50 |
ApexBio |
50 mg |
EUR 957.6 |
Description: SB743921 is an inhibitor of kinesin spindle protein (KSP) with Ki value of 0.1nM [1].As an inhibitor of mitotic kinesin KSP, SB743921 causes cell cycle arrest in mitosis, results in cell death. |
SB273005 |
B6003-25 |
ApexBio |
25 mg |
EUR 734.4 |
Description: SB 273005 is a potent nonpeptide antagonist of ?v?3 (vitronectin receptor), with Ki values of 1.2 nM and 0.3 nM to two closely related integrins, ?v?3 and ?v?5, respectively [1]. |
SB273005 |
B6003-5 |
ApexBio |
5 mg |
EUR 254.4 |
Description: SB 273005 is a potent nonpeptide antagonist of ?v?3 (vitronectin receptor), with Ki values of 1.2 nM and 0.3 nM to two closely related integrins, ?v?3 and ?v?5, respectively [1]. |
SB408124 |
B2163-10 |
ApexBio |
10 mg |
EUR 254.4 |
Description: SB408124 is a potent and novel nonpeptide antagonist of orexin-1 (OX(1)) receptor with Ki values of 27 nM and 57 nM in membrane formats and in whole cell, respectively. SB408124 was 50-fold selective over the human OX2 receptor [1]. |
SB408124 |
B2163-25 |
ApexBio |
25 mg |
EUR 494.4 |
Description: SB408124 is a potent and novel nonpeptide antagonist of orexin-1 (OX(1)) receptor with Ki values of 27 nM and 57 nM in membrane formats and in whole cell, respectively. SB408124 was 50-fold selective over the human OX2 receptor [1]. |
SB408124 |
B2163-5 |
ApexBio |
5 mg |
EUR 166.8 |
Description: SB408124 is a potent and novel nonpeptide antagonist of orexin-1 (OX(1)) receptor with Ki values of 27 nM and 57 nM in membrane formats and in whole cell, respectively. SB408124 was 50-fold selective over the human OX2 receptor [1]. |
SB408124 |
B2163-50 |
ApexBio |
50 mg |
EUR 710.4 |
Description: SB408124 is a potent and novel nonpeptide antagonist of orexin-1 (OX(1)) receptor with Ki values of 27 nM and 57 nM in membrane formats and in whole cell, respectively. SB408124 was 50-fold selective over the human OX2 receptor [1]. |
SB271046 |
B2255-10 |
ApexBio |
10 mg |
EUR 201.6 |
Description: SB-271046 is a selective and orally active 5-HT6 receptor antagonist.5-HT6 belongs to GPCR which stimulates adenylate cyclase via Gs, which cloned from rat striatum. |
SB271046 |
B2255-50 |
ApexBio |
50 mg |
EUR 614.4 |
Description: SB-271046 is a selective and orally active 5-HT6 receptor antagonist.5-HT6 belongs to GPCR which stimulates adenylate cyclase via Gs, which cloned from rat striatum. |
SB271046 |
B2255-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: SB-271046 is a selective and orally active 5-HT6 receptor antagonist.5-HT6 belongs to GPCR which stimulates adenylate cyclase via Gs, which cloned from rat striatum. |
SB742457 |
B2256-25 |
ApexBio |
25 mg |
EUR 518.4 |
Description: SB742457 is a selective antagonist of 5-HT6 receptor with a pKi value of 9.63 [1].SB742457 has been found to be a highly selective 5-HT6 receptor antagonist with high affinity to human 5-HT6 receptor. |
SB742457 |
B2256-5 |
ApexBio |
5 mg |
EUR 205.2 |
Description: SB742457 is a selective antagonist of 5-HT6 receptor with a pKi value of 9.63 [1].SB742457 has been found to be a highly selective 5-HT6 receptor antagonist with high affinity to human 5-HT6 receptor. |
SB742457 |
B2256-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 278.4 |
Description: SB742457 is a selective antagonist of 5-HT6 receptor with a pKi value of 9.63 [1].SB742457 has been found to be a highly selective 5-HT6 receptor antagonist with high affinity to human 5-HT6 receptor. |
SB505124 |
B2289-10 |
ApexBio |
10 mg |
EUR 226.8 |
Description: SB505124 is a selective and small molecule inhibitor of transforming growth Factor- ? type 1 receptors ALK4, ALK5 and ALK7 with the IC50 values of 129±11nM and 47±5nM for ALK4 and ALK5, respectively. |
SB505124 |
B2289-50 |
ApexBio |
50 mg |
EUR 630 |
Description: SB505124 is a selective and small molecule inhibitor of transforming growth Factor- ? type 1 receptors ALK4, ALK5 and ALK7 with the IC50 values of 129±11nM and 47±5nM for ALK4 and ALK5, respectively. |
SB-408124 |
E1KS1545 |
EnoGene |
5mg |
EUR 390 |
SB590885 |
E1KS2220 |
EnoGene |
10mg |
EUR 625.2 |
SB269970 HCl |
B2254-10 |
ApexBio |
10 mg |
EUR 297.6 |
Description: SB269970 HCl is a potent and selective antagonist of 5-HT7 receptor with pKi value of 8.3 [1].SB269970 is a selective antagonist of 5-HT7 receptor. It shows at least 100-fold selective against 5-HT7 over a variety of receptors and enzymes |
SB269970 HCl |
B2254-25 |
ApexBio |
25 mg |
EUR 591.6 |
Description: SB269970 HCl is a potent and selective antagonist of 5-HT7 receptor with pKi value of 8.3 [1].SB269970 is a selective antagonist of 5-HT7 receptor. It shows at least 100-fold selective against 5-HT7 over a variety of receptors and enzymes |
SB269970 HCl |
B2254-5 |
ApexBio |
5 mg |
EUR 184.8 |
Description: SB269970 HCl is a potent and selective antagonist of 5-HT7 receptor with pKi value of 8.3 [1].SB269970 is a selective antagonist of 5-HT7 receptor. It shows at least 100-fold selective against 5-HT7 over a variety of receptors and enzymes |
SB269970 HCl |
B2254-50 |
ApexBio |
50 mg |
EUR 999.6 |
Description: SB269970 HCl is a potent and selective antagonist of 5-HT7 receptor with pKi value of 8.3 [1].SB269970 is a selective antagonist of 5-HT7 receptor. It shows at least 100-fold selective against 5-HT7 over a variety of receptors and enzymes |
SB-334867 free base |
B3423-100 |
ApexBio |
100 mg |
EUR 718.8 |
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
SB-334867 free base |
B3423-25 |
ApexBio |
25 mg |
EUR 348 |
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
SB-334867 free base |
B3423-5 |
ApexBio |
5 mg |
EUR 153.6 |
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
SB-334867 free base |
B3423-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 157.2 |
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle. |
Ispinesib (SB-715992) |
A5343-10 |
ApexBio |
10 mg |
EUR 324 |
Description: Ispinesib (SB-715992) is a selective inhibitor of KSP with IC50 value of 0.5 nM [1]. Kinesin spindle protein (KSP) is a kinesin motor protein and plays an important role in the formation of a bipolar mitotic spindle and cell cycle progression through mitosis. |
Ispinesib (SB-715992) |
A5343-100 |
ApexBio |
100 mg |
EUR 1423.2 |
Description: Ispinesib (SB-715992) is a selective inhibitor of KSP with IC50 value of 0.5 nM [1]. Kinesin spindle protein (KSP) is a kinesin motor protein and plays an important role in the formation of a bipolar mitotic spindle and cell cycle progression through mitosis. |
Ispinesib (SB-715992) |
A5343-5 |
ApexBio |
5 mg |
EUR 234 |
Description: Ispinesib (SB-715992) is a selective inhibitor of KSP with IC50 value of 0.5 nM [1]. Kinesin spindle protein (KSP) is a kinesin motor protein and plays an important role in the formation of a bipolar mitotic spindle and cell cycle progression through mitosis. |
Ispinesib (SB-715992) |
A5343-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 452.4 |
Description: Ispinesib (SB-715992) is a selective inhibitor of KSP with IC50 value of 0.5 nM [1]. Kinesin spindle protein (KSP) is a kinesin motor protein and plays an important role in the formation of a bipolar mitotic spindle and cell cycle progression through mitosis. |
Ispinesib (SB-715992) |
A5343-50 |
ApexBio |
50 mg |
EUR 1005.6 |
Description: Ispinesib (SB-715992) is a selective inhibitor of KSP with IC50 value of 0.5 nM [1]. Kinesin spindle protein (KSP) is a kinesin motor protein and plays an important role in the formation of a bipolar mitotic spindle and cell cycle progression through mitosis. |
Ispinesib (SB-715992) |
E1KS1452 |
EnoGene |
5mg |
EUR 1048.8 |
EZSolution? SB-431542 |
1872-1 |
Biovision |
each |
EUR 189.6 |
EZSolution? SB-525334 |
2881-5 |
Biovision |
each |
EUR 248.4 |
Cilomilast (SB-207499) |
E1KS1455 |
EnoGene |
5mg |
EUR 625.2 |
SB-366791 (TRPV1 blocker) |
SIH-321-10MG |
Stressmarq |
10 mg |
EUR 214.8 |
|
Description: The substance SB-366791 is a trpv1 blocker. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 10 mM in ethanol and to 100 mM in DMSO. |
SB-366791 (TRPV1 blocker) |
SIH-321-50MG |
Stressmarq |
50 mg |
EUR 698.4 |
|
Description: The substance SB-366791 is a trpv1 blocker. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 10 mM in ethanol and to 100 mM in DMSO. |
SB-408124 Hydrochloride |
A3798-10 |
ApexBio |
10 mg |
EUR 254.4 |
Description: SB-408124 (SB 408124) is a selective non-peptide orexin OX1 receptor antagonist .(Kb values are 21.7 and 1405 nM for human OX1 and OX2 receptors respectively). SB-408124 (SB 408124) blocks orexin-A induced grooming following oral administration in vivo. |
SB-408124 Hydrochloride |
A3798-100 |
ApexBio |
100 mg |
EUR 1144.8 |
Description: SB-408124 (SB 408124) is a selective non-peptide orexin OX1 receptor antagonist .(Kb values are 21.7 and 1405 nM for human OX1 and OX2 receptors respectively). SB-408124 (SB 408124) blocks orexin-A induced grooming following oral administration in vivo. |
SB-408124 Hydrochloride |
A3798-5 |
ApexBio |
5 mg |
EUR 189.6 |
Description: SB-408124 (SB 408124) is a selective non-peptide orexin OX1 receptor antagonist .(Kb values are 21.7 and 1405 nM for human OX1 and OX2 receptors respectively). SB-408124 (SB 408124) blocks orexin-A induced grooming following oral administration in vivo. |
SB-408124 Hydrochloride |
A3798-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 201.6 |
Description: SB-408124 (SB 408124) is a selective non-peptide orexin OX1 receptor antagonist .(Kb values are 21.7 and 1405 nM for human OX1 and OX2 receptors respectively). SB-408124 (SB 408124) blocks orexin-A induced grooming following oral administration in vivo. |
SB-408124 Hydrochloride |
A3798-50 |
ApexBio |
50 mg |
EUR 667.2 |
Description: SB-408124 (SB 408124) is a selective non-peptide orexin OX1 receptor antagonist .(Kb values are 21.7 and 1405 nM for human OX1 and OX2 receptors respectively). SB-408124 (SB 408124) blocks orexin-A induced grooming following oral administration in vivo. |
SB-505124 hydrochloride |
A3799-10 |
ApexBio |
10 mg |
EUR 226.8 |
Description: SB505124 is a selective inhibitor of TGF?R for ALK4, ALK5 with IC50 value of 129 nM and 47 nM [1].Anaplastic lymphoma kinase (ALK) gets involved in the development of the brain and influence specific neurons in the nervous system. |
SB-505124 hydrochloride |
A3799-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 170.4 |
Description: SB505124 is a selective inhibitor of TGF?R for ALK4, ALK5 with IC50 value of 129 nM and 47 nM [1].Anaplastic lymphoma kinase (ALK) gets involved in the development of the brain and influence specific neurons in the nervous system. |
SB-505124 hydrochloride |
A3799-50 |
ApexBio |
50 mg |
EUR 630 |
Description: SB505124 is a selective inhibitor of TGF?R for ALK4, ALK5 with IC50 value of 129 nM and 47 nM [1].Anaplastic lymphoma kinase (ALK) gets involved in the development of the brain and influence specific neurons in the nervous system. |
Eltrombopag (SB-497115-GR) |
E1KS2229 |
EnoGene |
5mg |
EUR 625.2 |
SB203580 (p38 MAP kinase inhibitor) |
SIH-474-25MG |
Stressmarq |
25 mg |
EUR 985.2 |
|
Description: The substance SB203580 is a p38 map kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white powder which is soluble in DMSO (50 mg/ml). |
SB203580 (p38 MAP kinase inhibitor) |
SIH-474-5MG |
Stressmarq |
5 mg |
EUR 313.2 |
|
Description: The substance SB203580 is a p38 map kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white powder which is soluble in DMSO (50 mg/ml). |
SB216763 (GSK-3 kinase inhibitor) |
SIH-510-25MG |
Stressmarq |
25 mg |
EUR 548.4 |
|
Description: The substance SB216763 is a gsk-3 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is orange solid which is soluble in DMSO (>25 mg/ml). |
SB216763 (GSK-3 kinase inhibitor) |
SIH-510-5MG |
Stressmarq |
5 mg |
EUR 205.2 |
|
Description: The substance SB216763 is a gsk-3 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is orange solid which is soluble in DMSO (>25 mg/ml). |
SB1317 |
A3794-10 |
ApexBio |
10 mg |
EUR 390 |
Description: SB1317 is a potent inhibitor of Cyclin dependent kinases (CDKs), FMS-like tyrosine kinase-3 (FLT3) and Janus kinase 2 (JAK2) with IC50 values of 13nM, 56nM and 73nM for CDK2, JAK2 and FLT3, respectively [1]. |
SB1317 |
A3794-100 |
ApexBio |
100 mg |
EUR 1243.2 |
Description: SB1317 is a potent inhibitor of Cyclin dependent kinases (CDKs), FMS-like tyrosine kinase-3 (FLT3) and Janus kinase 2 (JAK2) with IC50 values of 13nM, 56nM and 73nM for CDK2, JAK2 and FLT3, respectively [1]. |
SB1317 |
A3794-5 |
ApexBio |
5 mg |
EUR 278.4 |
Description: SB1317 is a potent inhibitor of Cyclin dependent kinases (CDKs), FMS-like tyrosine kinase-3 (FLT3) and Janus kinase 2 (JAK2) with IC50 values of 13nM, 56nM and 73nM for CDK2, JAK2 and FLT3, respectively [1]. |
SB1317 |
A3794-50 |
ApexBio |
50 mg |
EUR 783.6 |
Description: SB1317 is a potent inhibitor of Cyclin dependent kinases (CDKs), FMS-like tyrosine kinase-3 (FLT3) and Janus kinase 2 (JAK2) with IC50 values of 13nM, 56nM and 73nM for CDK2, JAK2 and FLT3, respectively [1]. |
SB431542 (ALK4,5 and 7 kinase inhibitor) |
SIH-511-25MG |
Stressmarq |
25 mg |
EUR 716.4 |
|
Description: The substance SB431542 is a alk4,5 and 7 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow solid which is soluble to 10 mM in ethanol and to 100 mM in DMSO. |
SB431542 (ALK4,5 and 7 kinase inhibitor) |
SIH-511-5MG |
Stressmarq |
5 mg |
EUR 238.8 |
|
Description: The substance SB431542 is a alk4,5 and 7 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow solid which is soluble to 10 mM in ethanol and to 100 mM in DMSO. |
SB-203580 p38 MAPK(p38 MAP kinase) Inhibitor |
E1B1863 |
EnoGene |
1mg |
EUR 193.2 |
VS-5584 (SB2343) |
A3927-10 |
ApexBio |
10 mg |
EUR 226.8 |
Description: VS-5584 (SB2343), a purine analog, is a novel small-molecule inhibitor of both mammalian target of rapamycin (mTOR) kinase and all class I phosphoinostide 3-kinase (PI3K) isoforms that ATP-competitively inhibits the activity of mTOR, PI3K?, PI3K?, PI3K? and PI3K?. |
VS-5584 (SB2343) |
A3927-5 |
ApexBio |
5 mg |
EUR 184.8 |
Description: VS-5584 (SB2343), a purine analog, is a novel small-molecule inhibitor of both mammalian target of rapamycin (mTOR) kinase and all class I phosphoinostide 3-kinase (PI3K) isoforms that ATP-competitively inhibits the activity of mTOR, PI3K?, PI3K?, PI3K? and PI3K?. |
VS-5584 (SB2343) |
A3927-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 196.8 |
Description: VS-5584 (SB2343), a purine analog, is a novel small-molecule inhibitor of both mammalian target of rapamycin (mTOR) kinase and all class I phosphoinostide 3-kinase (PI3K) isoforms that ATP-competitively inhibits the activity of mTOR, PI3K?, PI3K?, PI3K? and PI3K?. |
VS-5584 (SB2343) |
A3927-50 |
ApexBio |
50 mg |
EUR 616.8 |
Description: VS-5584 (SB2343), a purine analog, is a novel small-molecule inhibitor of both mammalian target of rapamycin (mTOR) kinase and all class I phosphoinostide 3-kinase (PI3K) isoforms that ATP-competitively inhibits the activity of mTOR, PI3K?, PI3K?, PI3K? and PI3K?. |
VS-5584 (SB2343) |
A3927-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: VS-5584 (SB2343), a purine analog, is a novel small-molecule inhibitor of both mammalian target of rapamycin (mTOR) kinase and all class I phosphoinostide 3-kinase (PI3K) isoforms that ATP-competitively inhibits the activity of mTOR, PI3K?, PI3K?, PI3K? and PI3K?. |
EZSolution? SB-431542, Sterile-Filtered |
1992-1 |
Biovision |
each |
EUR 326.4 |
SB1518 (Pacritinib) |
2450-1 |
Biovision |
each |
EUR 210 |
SB1518 (Pacritinib) |
2450-5 |
Biovision |
each |
EUR 652.8 |
Pacritinib (SB1518) |
B1589-10 |
ApexBio |
10 mg |
EUR 532.8 |
Description: Pacritinib is a small molecule inhibitor of Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) with IC50 values of 23nM, 19nM and 22nM, respectively for JAK2WT, JAK2V617F and FLT3 [1]. |
Pacritinib (SB1518) |
B1589-25 |
ApexBio |
25 mg |
EUR 1104 |
Description: Pacritinib is a small molecule inhibitor of Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) with IC50 values of 23nM, 19nM and 22nM, respectively for JAK2WT, JAK2V617F and FLT3 [1]. |
Pacritinib (SB1518) |
B1589-5 |
ApexBio |
5 mg |
EUR 348 |
Description: Pacritinib is a small molecule inhibitor of Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) with IC50 values of 23nM, 19nM and 22nM, respectively for JAK2WT, JAK2V617F and FLT3 [1]. |
Pacritinib (SB1518) |
B1589-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 602.4 |
Description: Pacritinib is a small molecule inhibitor of Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) with IC50 values of 23nM, 19nM and 22nM, respectively for JAK2WT, JAK2V617F and FLT3 [1]. |
Pacritinib (SB1518) |
B1589-50 |
ApexBio |
50 mg |
EUR 2005.2 |
Description: Pacritinib is a small molecule inhibitor of Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) with IC50 values of 23nM, 19nM and 22nM, respectively for JAK2WT, JAK2V617F and FLT3 [1]. |
SB939 |
E1KS1515 |
EnoGene |
50mg |
EUR 4164 |
Monoclonal KCNJ12 / Kir2.2 Antibody (aa362-427, clone S124B-38), Clone: S124B-38 |
AMM06101G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A Monoclonal antibody against Human KCNJ12 / Kir2.2 (aa362-427, clone S124B-38). The antibodies are raised in Mouse and are from clone S124B-38. This antibody is applicable in WB and IHC-P, IF, ICC |
Pracinostat (SB939) |
27771-1 |
BPS Bioscience |
10 mg |
EUR 275 |
Description: Potent and oral inhibitor of histone deacetylase (HDAC), selective for class I, II and IV HDACs. SB939 shows significant antiproliferative activity against a wide variety of tumor cell lines, with high tumor exposure and efficacy in mouse models of colorectal cancer. |
Pracinostat (SB939) |
27771-2 |
BPS Bioscience |
5 mg |
EUR 190 |
Description: Potent and oral inhibitor of histone deacetylase (HDAC), selective for class I, II and IV HDACs. SB939 shows significant antiproliferative activity against a wide variety of tumor cell lines, with high tumor exposure and efficacy in mouse models of colorectal cancer. |
Pracinostat (SB939) |
27771-3 |
BPS Bioscience |
50 mg |
EUR 700 |
Description: Potent and oral inhibitor of histone deacetylase (HDAC), selective for class I, II and IV HDACs. SB939 shows significant antiproliferative activity against a wide variety of tumor cell lines, with high tumor exposure and efficacy in mouse models of colorectal cancer. |
Pracinostat (SB939) |
A4095-10 |
ApexBio |
10 mg |
EUR 351.6 |
Description: Pracinostat, also known as SB939, is a potent and orally available inhibitor of histone deacetylase (HDAC) with a relatively stronger selectivity (more than 1000-fold) for class I, class II and class IV HDACs rather than class III HDACs. |
Pracinostat (SB939) |
A4095-5 |
ApexBio |
5 mg |
EUR 219.6 |
Description: Pracinostat, also known as SB939, is a potent and orally available inhibitor of histone deacetylase (HDAC) with a relatively stronger selectivity (more than 1000-fold) for class I, class II and class IV HDACs rather than class III HDACs. |
Pracinostat (SB939) |
A4095-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 236.4 |
Description: Pracinostat, also known as SB939, is a potent and orally available inhibitor of histone deacetylase (HDAC) with a relatively stronger selectivity (more than 1000-fold) for class I, class II and class IV HDACs rather than class III HDACs. |
Pracinostat (SB939) |
A4095-50 |
ApexBio |
50 mg |
EUR 908.4 |
Description: Pracinostat, also known as SB939, is a potent and orally available inhibitor of histone deacetylase (HDAC) with a relatively stronger selectivity (more than 1000-fold) for class I, class II and class IV HDACs rather than class III HDACs. |
Pracinostat (SB939) |
A4095-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: Pracinostat, also known as SB939, is a potent and orally available inhibitor of histone deacetylase (HDAC) with a relatively stronger selectivity (more than 1000-fold) for class I, class II and class IV HDACs rather than class III HDACs. |
S100B(S100B/1012) Antibody |
BNC401012-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against S100B(S100B/1012), CF640R conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC401012-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against S100B(S100B/1012), CF640R conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC551012-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against S100B(S100B/1012), CF555 conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC551012-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against S100B(S100B/1012), CF555 conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC431012-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against S100B(S100B/1012), CF543 conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC431012-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against S100B(S100B/1012), CF543 conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC471012-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against S100B(S100B/1012), CF647 conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC471012-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against S100B(S100B/1012), CF647 conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC801012-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against S100B(S100B/1012), CF680 conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC801012-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against S100B(S100B/1012), CF680 conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC811012-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against S100B(S100B/1012), CF680R conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC811012-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against S100B(S100B/1012), CF680R conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC611012-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against S100B(S100B/1012), CF660R conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC611012-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against S100B(S100B/1012), CF660R conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNUM1012-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against S100B(S100B/1012), 1mg/mL |
S100B(S100B/1012) Antibody |
BNCP1012-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against S100B(S100B/1012), PerCP conjugate, Concentration: 0.1mg/mL |
S100B(S100B/1012) Antibody |
BNC941012-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against S100B(S100B/1012), CF594 conjugate, Concentration: 0.1mg/mL |
SB202190